Atheroscleroses
12
4
5
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (12)
wCAR-Austria: A Women-Specific Score to Assess Cardiovascular Risk in Women Aged 40 to 65
Atherosclerosis in Early Rheumatoid Arthritis Patients Using Atherogenic Index of the Plasma and Carotid Intima Media Thickness
Development and Validation of a Scale of Propensity for Change in Chronic Disease Prevention
Clinical Impact of Using IMPROVE to Select Patients for Carotid Revascularisation
A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease
TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men
Drug-Eluting Balloon Treatment vs. Guideline-Directed Medical Therapy for the Treatment of Lipid-Rich Plaques
Exploring Sustainable Alternatives to Marine Oils With Echium and Ahiflower Oils
A Cohort Study on Cardiovascular and Cerebrovascular Outcomes
Mediterranean Diet Education in Shift Nurses: Effects on Sleep, Activity, and Health Parameters
Ultrasound Assessment of Atherosclerotic Plaque Burden and Cardiovascular Risk: A 10-Year Prospective Study
Pulmonary Disease in Patients Referred for Coronary CT